MED - Medifast, Inc.

NYSE - NYSE Delayed Price. Currency in USD
Show:
Income Statement
Balance Sheet
Cash Flow
Annual

Income Statement

All numbers in thousands
Breakdown
ttm
Total Revenue
638,062
Cost of Revenue
155,913
Gross Profit
482,149
Operating Expenses
Research Development
-
Selling General and Administrative
392,809
Total Operating Expenses
392,809
Operating Income or Loss
89,340
Interest Expense
-
Total Other Income/Expenses Net
-7
Income Before Tax
90,797
Income Tax Expense
19,230
Income from Continuing Operations
71,567
Net Income
71,567
Net Income available to common shareholders
71,567
Reported EPS
Basic
-
Diluted
-
Weighted average shares outstanding
Basic
-
Diluted
-
EBITDA
-